Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

948.45 -26.51 (-2.72%)

Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Hims & Hers Jumps On Its New Eli Lilly-Tied Approach To Obesity ↗

April 23, 2026

Hims & Hers Health can now connect its customers with self-pay prices for Eli Lilly's weight-loss drugs.

Via Investor's Business Daily

Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap? ↗

April 23, 2026

Novo Nordisk stock has been stuck in a downward spiral for quite some time.

Via The Motley Fool

The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

April 23, 2026

From stem cell therapies for frailty to α-Klotho protein programs and GLP-1 drug classes now labeled "longevity therapeutics," the science and the capital have finally met

From Equity Insider

Via GlobeNewswire

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins ↗

April 23, 2026

Drugmakers won't be the only ones cashing in on the rising popularity of weight loss medicines.

Via The Motley Fool

ELI LILLY & CO (NYSE:LLY): A High-Quality Dividend Growth Stock for Patient Investors ↗

April 20, 2026

Via Chartmill

Eli Lilly & Co (NYSE:LLY): A Growth Stock Showing Technical Setup for a Potential Breakout ↗

April 18, 2026

Via Chartmill

3 Healthcare Stocks With the Most Durable Competitive Moats ↗

April 23, 2026

These companies offer a clear path to sustained earnings growth.

Via The Motley Fool

Topics Intellectual Property

Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks

April 22, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the pharmaceuticals stocks, including Elanco (NYSE:ELAN) and its peers. The pharmaceuti...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation. ↗

April 22, 2026

Eli Lilly stock trades for more than $900 per share, which may appear expensive upon first glance.

Via The Motley Fool

Why Merck (MRK) Shares Are Trading Lower Today

April 21, 2026

What Happened? Shares of global pharmaceutical company Merck (NYSE:MRK) fell 3.8% in the afternoon session after the company, along with its partner Eisai, a...

Via StockStory

Topics Government Intellectual Property

Eli Lilly and Novo Nordisk's Newest Rival In Weight Loss? Amazon. ↗

April 21, 2026

Shares of Eli Lilly, Novo Nordisk and Viking Therapeutics fell Tuesday after Amazon announced it would sell weight-loss drugs.

Via Investor's Business Daily

Why Did Eli Lilly Stock Drop Today? ↗

April 21, 2026

Can Eli Lilly cure cancer? Maybe -- with a little help.

Via The Motley Fool

Which S&P500 stocks are gapping on Tuesday? ↗

April 21, 2026

Via Chartmill

A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly ↗

April 21, 2026

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.

Via The Motley Fool

After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up ↗

April 21, 2026

Via Chartmill

Why Legend Biotech Stock Crushed the Market on Monday ↗

April 20, 2026

Two analysts weighed in positively about the company's future.

Via The Motley Fool

3 Giant Dividend Stocks Raising Payouts With Yields Up to 4% ↗

April 20, 2026

Johnson & Johnson, Albertsons, and Procter & Gamble have each raised their dividends, lifting yields to between 2.3% and 4% despite mixed performance in 2025.

Via MarketBeat

Eli Lilly Goes Atomic—But This Isn't About AI Servers ↗

April 20, 2026

Eli Lilly's nuclear move signals a shift beyond AI, as industrial giants like Nucor and Dow turn to reactors for reliable, 24/7 power.

Via Benzinga

Topics Artificial Intelligence Stocks

Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others ↗

April 20, 2026

Eli Lilly said Monday it will spend up to $7 billion to buy privately held Kelonia Therapeutics for its suite of cancer drugs.

Via Investor's Business Daily

Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? ↗

April 20, 2026

Regulators approved the company's GLP-1 weight loss pill, Foundayo, at the beginning of April.

Via The Motley Fool

Eli Lilly (LLY): 3 Reasons We Love This Stock

April 20, 2026

Eli Lilly currently trades at $926.10 and has been a dream stock for shareholders. It’s returned 386% since April 2021, blowing past the S&P 500’s 70.2% gain...

Via StockStory

Topics Stocks

2 Millionaire-Maker Stocks to Hold for the Next 10 Years ↗

April 19, 2026

No need for a time machine to profit from these companies.

Via The Motley Fool

Topics Artificial Intelligence

This Drug Stock Has Crushed the S&P 500 Over the Last Decade ↗

April 18, 2026

Eli Lilly is leading the GLP-1 charge, but investors have already priced much of the good news into the stock.

Via The Motley Fool

Topics Intellectual Property Stocks

Better Long-Term Buy: Eli Lilly or Viking Therapeutics? ↗

April 17, 2026

One is a behemoth, the other is a minnow, but both have promising opportunities in the GLP-1 space.

Via The Motley Fool

Topics Artificial Intelligence

Is This the Biggest Game-Changer in Lilly's 150-Year History? ↗

April 17, 2026

The company's recent dip may be a buying opportunity.

Via The Motley Fool

Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake ↗

April 17, 2026

Eli Lilly obesity pill logs 1,390 U.S. scripts in first week, trailing Novo's oral Wegovy as competition in weight-loss drugs intensifies.

Via Benzinga

3 Ways to Invest in the Growing GLP-1 Weight Loss Market ↗

April 17, 2026

Via MarketBeat

Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. ↗

April 17, 2026

Eli Lilly's oral weight-loss drug, Foundayo, nabbed 1,390 prescriptions in its first week on the market, analysts said Friday.

Via Investor's Business Daily

Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026? ↗

April 17, 2026

The stock could have plenty of room to run from current levels.

Via The Motley Fool

3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗

April 16, 2026

These companies boast significant upside potential.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.